The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: Recent advances

American Journal of Kidney Diseases

Volumn 28, Issue 6, 1996, Pages 788-803

  Grantham, Jared J ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

cysts; genes; genetics; heredity; Renal; renal failure

Indexed keywords

BICARBONATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHYLPREDNISOLONE; MEVINOLIN; PACLITAXEL; PROTEIN;

AUTOSOMAL DOMINANT DISORDER; CELL PROLIFERATION; CYST FLUID; DRUG EFFECT; DRUG MECHANISM; ELECTROLYTE TRANSPORT; EXTRACELLULAR MATRIX; GENE MUTATION; HUMAN; KIDNEY POLYCYSTIC DISEASE; NONHUMAN; POTASSIUM INTAKE; PROTEIN RESTRICTION; REVIEW;

EID: 0029823868     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90378-9     Document Type: Review

References (105)

1. Reeders ST, Breuning MH, Davies KE, Nichols RD, Jarman AP, Higgs DR, Pearson PL, Weatherall DJ: A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 317:542-544, 1985
2. Kimberling WJ, Kumar S, Gabow PA, Kenyon JB, Connolly CJ, Somlo S: Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4ql3-123. Genomics 18:467-472, 1993
3. Daoust MC, Reynolds BM, Bichet DT, Somlo S: Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Nat Genet 5:359-362, 1995
4. Germino GO, Weinstat-Saslow D, Himmelbauer H, Gillespie GAJ, Somlo S, Wirth B, Barton N, Harris KL, Frischauf A-M, Reeders ST: The gene for autosomal dominant polycystic kidney disease lies in a 750-kb CpG-rich region. Genomics 13:144-151, 1992
5. European Polycystic Kidney Disease Consortium: The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77:881-894, 1994
6. The American PKD1 Consortium: Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. Hum Mol Genet 4:575-582, 1995
7. International Polycystic Kidney Disease Consortium: Polycystic kidney disease: The complete structure of the PKD1 gene and its protein. Cell 81:2189-2198, 1995
8. Hughes J, Ward CJ, Belen P, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC: The polycystic kidney disease l (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10:151-160, 1995
9. Mochizuki T, Wu Guanqing, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow P, Pendes A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJM, Somlo S: PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272:1339-1342, 1996
10. Van Adelsberg JS, Frank D: The PKD1 gene product is a developmentally regulated extracellular matrix protein in mesenchyme and vasculature. Nat Med 1:359-364, 1995
11. Ward CJ, Turley H, Ong ACM, Comley M, Ciddolph S, Chetty R, Ratcliffe PJ, Gatter K, Harris PC: Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc Natl Acad Sei U S A 93:1524-1528, 1996
12. Griffin MD, Torres VE, Grande JP, Kumar R: Immunolocalization of polycystin in human tissues and cultured cells. Proc Am Assoc Physicians 108:185-197, 1996
13. Onuchic L, Wilson P, O'Sullivan E, Hebert R, Germino G: Polycystin is developmentally regulated and increased in human cystic epithelium. J Am Soc Nephrol 6:705, 1995 (abstr)
14. Peters DJM, Klingel R, Bernini L, de Heer E, Breuning MH, Bruijn JA: Immunohistochemical analysis of renal tissue with polyclonal antibodies against peptides encoded by the predicted ADPKD1-protein. J Am Soc Nephrol 6:706, 1995 (abstr)
15. Geng L, Peissel B, Deng N, Rennke HG, York P, Glucksmann-Kuis S, Schneider M, Reeders ST, Zhou J: Polycystin, the product of the PKD1 gene. J Am Soc Nephrol 6:695, 1995 (abstr)
16. Palsson R, McLaughlin M, Sharma CP, Brown D, Arnaout MA: immunolocalization of PKD1 in normal kidneys. J Am Soc Nephrol 6:705, 1995 (abstr)
17. Peral B, San-Millan JL, Ong AC, Gamble V, Ward CJ, Strong C, Harris PC: Screening the 3' region of the polycystic kidney disease l (PKD1) gene reveals six novel mutations. Am J Hum Genet 58:86-96, 1996
18. Fine L: Gene transfer into the kidney: Promise for unravelling disease mechanisms, limitations for human gene therapy. Kidney Int 49:612-619, 1996
19. Grantham JJ: Polycystic kidney disease: Neoplasia in disguise. Am J Kidney Dis 15:110-116, 1990
20. Qian F, Onuchic L, Watnick T, Tan SS, Germino GG: Analysis of the clonal nature of ADPKD cysts. J Am Soc Nephrol 6:707, 1995 (abstr)
21. Cowley BD, Jr, Gudapaty S, Kraybill AL, Barash BD, Harding MA, Calvet JP, Gattone VHII: Autosomal-dominant polycystic kidney disease in the rat. Kidney Int 43:522-534, 1993
22. Nadasdy T, Lasizik Z, Lajoie G, Blick KE, Wheeler DE, Suva FG: Proliferative activity of cyst epithelium in human renal cystic diseases. J Am Soc Nephrol 5:1462-1468, 1995
23. Grantham JJ, Geiser JL, Evan AP: Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int 31:1145-1152, 1987
24. Cowley BD, Jr, Smardo FL, Grantham JJ, Calvet JP: Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease. Proc Natl Acad Sei U S A 84:8394-8398, 1987
25. Cowley BD, Chadwick LF, Grantham JJ, Calvet JP: Elevated proto-oncogene expression in polycystic kidneys of the C57BL/6J (cpk) mouse. J Am Soc Nephrol 1:1048-1053, 1991
26. Wilson PD: Pathogenesis of polycystic kidney disease: Altered cellular function, in Watson ML, Torres VE (eds): Polycystic Kidney Disease. Oxford, UK, Oxford University Press, 1996, pp 125-163
27. Klingel R, Dippold W, Storkel S, Meyer K, Kohler H: Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease and renal cell carcinoma. Am J Kidney Dis 19:2230, 1992
28. MacKay K, Striker LJ, Pinkert CA, Brinster RL, Striker GE: Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40. Kidney Int 32:827837, 1987
29. Kelley KA, Agarwal N, Reeders S, Hemp K: Renal cyst formation and multifocal neoplasia in transgenic mice carrying the Simian virus 40 early region. J Am Soc Nephrol 2:84-97, 1991
30. Dressier GR, Wilkinson JE, Rothenpieler UW, Patterson LT, Williams-Simons L, Westphal H: Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 362:65-67, 1993
31. Stocklin E, Botteri F, Groner B: An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice. J Cell Biol 122:199-208, 1993
32. Trudel M, D'Agati V, Costantini F: c-myc As an inducer of polycystic kidney disease in transgenic mice. Kidney Int 39:665-671, 1991
33. Schaffner DL, Barrios R, Massey C, Banez El, Ou CN, Rajagopalan S, Aguilar-Cordova E, Lebovitz RM, Overbeek PA, Lieberman MW: Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys. Am J Pathol 142:10511060, 1993
34. Carone FA, Nakamura S, Schumacher BS, Punyarit P, Bauer K: Cyst-derived cells do not exhibit accelerated growth or features of transformed cells in vitro. Kidney Int 35:13511357, 1989
35. Woo D: Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 333:18-25, 1995
36. Winyard PJD, Nauta J, Lirenman DS, Hardman P, Sams VR, Risdon RA, Woolf AS: Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int 49:135-146, 1996
37. Duncan KA, Cuppage FE, Grantham JJ: Urinary lipid bodies in polycystic kidney disease. Am J Kidney Dis 5:4953, 1985
38. Veis DJ, Sorenson CM, Shutter JR, Korsemeyer SJ: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell 75:229-240, 1993
39. Dvergsten J, Manivel JC, Correa-Rotter R, Rosenberg ME: Expression of clustering in human renal disease. Kidney Int 45:828-835, 1994
40. Eng E, Wilson PD, Racusen L, Burrow CR: Aberrant Pax-2-expression in human autosomal dominant polycystic disease epithelia. J Am Soc Nephrol 5:621, 1994 (abstr)
41. Du J, Wilson PD: Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am J Physiol 269:C487-495, 1995
42. Grantham JJ: Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts. J Am Soc Nephrol 3:1843-1857, 1993
43. Rankin CA, Grantham JJ, Calvet JP: c-fos Expression is hypersensitive to serum-stimulation in cultured cystic kidney cells from the C57Bl/6J-cpk mouse. J Cell Physiol 152:578-586, 1992
44. Calvet JP: Injury and development in polycystic kidney disease. Curr Opin Nephrol Hypertens 3:340-348, 1994
45. Wilson PD, Schrier RW, Breckon RD, Gabow PA: A new method for studying human polycystic kidney disease epithelia in culture. Kidney Int 30:371-378, 1986
46. Neufeld TK, Grant ME, Grantham JJ: A method to measure the rate of net fluid secretion by monolayers of cultured renal epithelial cells. J Tissue Culture Methods 13:229-234, 1991
47. Carone FA, Nakamura S, Bacallao R, Nelson WJ, Khokha M, Kanwar Y: Impaired tubulogenesis of cyst-derived cells from autosomal dominant polycystic kidneys. Kidney Int 47:861-868, 1995
48. Grantham JJ, Ye M, Gattone VH II, Sullivan LP: In vitro fluid secretion by epithelium from polycystic kidneys. J Clin Invest 95:195-202, 1995
49. Wilson PD, Du J, Norman JT: Automne, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease. Eur J Cell Biol 61:131-138, 1993
50. Mangoo-Karim R, Uchic ME, Grant M, Shumate WA, Calvet JP, Park CH, Grantham JJ: Renal epithelial fluid secretion and cyst growth: The role of cyclic AMP. FASEB J 3:2629-2632, 1989
51. Wallace DP, Grantham JJ, Sullivan LP: Chloride and fluid secretion by cultured human polycystic kidney cells. Kidney Int (submitted)
52. Neufeld TK, Douglass D, Grant M, Ye M, Suva F, Nadasdy T, Grantham JJ: In vitro formation and expansion of cysts derived from human renal cortex epithelial cells. Kidney Int 41:1222-1236, 1992
53. Ye M, Grant M, Sharma L, Elzinga L, Swan S, Torres VE, Grantham JJ: Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro. J Am Soc Nephrol 3:984994, 1992
54. Gabow PA: Autosomal dominant polycystic kidney disease. N Engl J Med 329:332-342, 1993
55. Cuppage FE, Huseman RA, Chapman A, Grantham JJ: Ultrastructure and function of cysts from human adult polycystic kidneys. Kidney Int 17:372-381, 1980
56. Katz SK, Hakki A, Miller AS, Finkelstein S: Ultrastructural tubular basement membrane lesions in adult polycystic kidney disease. Ann Clin Lab Sei 19:352-359, 1989
57. Calvet JP: Polycystic kidney disease: Primary extracellular matrix abnormality or defective cellular differentiation? Kidney Int 43:101-108, 1993
58. Carone FA, Bacallao R, Kanwar Y: Biology of polycystic kidney disease. Lab Invest 70:437-448, 1994
59. Liu ZZ, Carone FA, Nakumara S, Kanwar YS: Altered synthesis of proteoglycans by cyst-derived cells from autosomal-dominant polycystic kidneys. Am J Physiol 263:F697704, 1992
60. Granot Y, Van Putten V, Przekwas J, Gabow PA, Schrier RW: Intra- and extracellular proteins in human normal and polycystic kidney epithelial cells. Kidney Int 37:1301-1309, 1990
61. Candiano G, Gusmano R, Altieri P, Bertelli R, Ginevri F, Coviello DA, Sessa A, Caridi G, Ghiggeri CM: Extracellu-lar matrix formation by epithelial cells from human polycystic kidney cysts in culture. Virchows Arch B Cell Pathol 63:1-9, 1992
62. Kovacs J, Carone F, Liu ZZ, Nakumara S, Kumar A, Kamvar YS: Differential growth factor-induced modulation of proteoglycans synthesized by normal human renal versus cyst-derived cells, J Am Soc Nephrol 5:47-54, 1994
63. Wilson PD, Hreniuk D, Gabow PA: Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia. J Cell Physiol 150:360-369, 1992
64. Klingel R, Ramadori G, Schuppan D, Knittel T, Meyer zum Buschenfelde K-H, Kohler H: Coexpression of extracellular matrix glycoproteins undulin and tenascin in human autosomal dominant polycystic kidney disease, Nephron 65:111-118, 1993
65. Carone FA, Makino H, Kanwar YS: Basement membranes in experimental renal cystic disease. Am J Pathol 130:466-471, 1988
66. Zeier M, Fehrenbach P, Geberth S, Mohring K, Waldherr R, Ritz E: Renal histology in polycystic kidney disease with incipient and advanced renal failure. Kidney Int 42:1259-1265, 1992
67. Rankin CA, Suzuki K, Ziemer DM, Grantham JJ, Calvet JP, Nagase H: 72-kDa gelatinase A (MMP-2) is found in cyst fluid of 32 human patients and three rodent models of PKD. J Am Soc Nephrol 6:707, 1995 (abstr)
68. Norman JT, Gatti L, Wilson PD, Lewis M: Matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases expression by tubular epithelia and interstitial fibroblasts in the normal kidney and in fibrosis. Exp Nephrol 3:8889, 1995
69. Gardner KD, Jr, Burnside JS, Elzinga L, Locksley RM: Cytokines in fluids from polycystic kidneys. Kidney Int 39:718-724, 1991
70. Carone FA, Bacallao R, Kanwar YS: Pathogenesis of polycystic kidney disease: Basement membrane and extracellular matrix, in Watson ML, Torres VE (eds): Polycystic Kidney Disease. Oxford, UK, Oxford University Press, 1996, pp 111-124
71. Bacallao R, Fine LG: Molecular events in the organization of renal tubular epithelium: From nephrogenesis to regeneration. Am J Physiol 257:F913-F924, 1989
72. Gardner KD, Jr, Burnside JS, Skipper BJ, Bennett WM, Connors BA, Evan AP: On the probability that kidneys are different in autosomal dominant polycystic disease. Kidney Int 42:1199-1206, 1992
73. Huseman R, Grady A, Welling D, Grantham J: Macropuncture study of polycystic disease in adult human kidneys. Kidney Int 18:375-385, 1980
74. 2 microglobulin in autosomal dominant polycystic kidney disease. Kidney Int 31:85-92, 1987
75. Bachinsky DR, Sabolic I, Emmanouel DS, Jefferson DM, Carone FA, Brown D, Perrone RD: Water channel expression in human ADPKD kidneys. Am J Physiol 268:F398403, 1995
76. Welling LW, Welling DJ: Kinetics of cyst development in cystic disease, in Cummings NB, Klahr S (eds): Chronic Renal Disease. New York, NY, Plenum, 1985, pp 95-103
77. Tanner GA, McQuillan PF, Maxwell MR, Keck JK, McAteer JA: An in vitro test of the cell stretch-proliferation hypothesis of renal cyst enlargement. J Am Soc Nephrol 6:1230-1241, 1995
78. Ye M, Grantham JJ: The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease. N Engl J Med 329:310-313, 1993
79. Perrone RD: In vitro function of cyst epithelium from human polycystic kidney. J Clin Invest 76:1688-1691, 1985
80. Mangoo-Karim R, Ye M, Wallace DP, Grantham JJ, Sullivan LP: Anion secretion drives fluid secretion by monolayers of cultured human polycystic cells. Am J Physiol 269:F381-F388, 1995
81. Grantham JJ: Fluid secretion in the nephron: Relation to renal failure. Physiol Rev 56:248-258, 1976
82. Rocha AS, Kudo LH: Atrial peptide and cGMP effects on NaCl transport in inner medullary collecting duct. Am J Physiol 259:F258-F268, 1990
83. Beyenbach KVV: Secretory NaCl and volume flow in renal tubules. Am J Physiol 250:R753-R763, 1986
84. Wingo CS: Active and passive chloride transport by the rabbit cortical collecting duct. Am J Physiol 258:F1388F1393, 1990
85. Everson GT, Emmett M, Brown WR, Redmond P, Thickman D: Functional similarities of hepatic cystic and biliary epithelium: Studies of fluid constituents and in vivo secretion in response to secretin. Hepatology 11:557-565, 1990
86. Davidovv CJ, Maser RJ, Rome L, Calvet JP, Grantham JJ: Cystic fibrosis transmembrane conductance regulator (CFTR) mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease (ADPKD) epithelium in vitro. Kidney Int 58:208-218, 1996
87. Wilson PD, Sherwood AC, Palla K, Du J, Watson R, Norman JT: Reversed polarity of Na + K, ATPase: Mislocation to apical plasma membranes in polycystic kidney disease epithelia. Am J Physiol 260:F420-F430, 1991
88. Sullivan LP, Wallace DP, Grantham JJ: Coupling of cell volume and membrane potential changes to fluid secretion in a model of renal cysts. 45:1369-1380, 1994
89. Hanaoka D, Devuyst O, Schwiebert EM, Wilson PD, Guggino WB: A role for CFTR in human autosomal dominant polycystic kidney disease. Am J Physiol 270:C389-C399, 1996
90. Brill S, Ross KE, Davidow CJ, Ye M, Grantham JJ, Caplan MJ: Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells. Proc NatI Acad Sei (in press)
91. O'Brodovich HM: Maturation of solute transport mechanisms in pulmonary epithelia. Kidney Int 47:721-722, 1995
92. Welsh MJ, Smith PL, Fromm M, Frizzell RA: Crypts are the site of intestinal fluid and electrolyte secretion. Science 218:1219-1221, 1982
93. Gardner KD, Jr, Glew RH, Evan AP, McAteer JA, Bernstein J: Why renal cysts grow. Am J Physiol 266:F353-359, 1994
94. Klahr S, Breyer JA, Beck GJ, Dennis VW, Hartman JA, Roth D, Steinman TI, Wang S-R, Yamamoto ME: Dietary protein restriction, blood pressure control and the progression of polycystic kidney disease. J Am Soc Nephrol 5:2037-2047, 1995
95. Tomobe K, Philbrick D, Aukema HM, Clark WF, Ogbom MR, Parbtani A, Takahashi DH, Holub BJ: Early dietary protein restriction slows disease progression and lengthens survival in mice with polycystic kidney disease. J Am Soc Nephrol 5:1355-1360, 1994
96. Cowley BD, Jr, Grantham JJ, Muessel MJ, Kraybill AL, Gattone VH II: Modification of disease progression in rats with inherited polycystic kidney disease. Am J Kidney Dis 27:865-879, 1996
97. Gabow PA: Definition and natural history of autosomal dominant polycystic kidney disease, in Watson ML, Torres VE (eds): Polycystic Kidney Disease. Oxford, UK, Oxford University Press, 1996, pp 333-355
98. Watson ML: Hypertension in polycystic disease, in Watson ML, Torres VE (eds): Polycystic Kidney Disease. Oxford, UK, Oxford University Press, 1996, pp 408-429
99. Maschio G, Albert! D, Janin G, Locatelli F, Mann JFE, Motolese M, Ponticelli C, Ritz E, Zucchelli P: Angiotensinconverting-enzyme inhibition in progressive renal insufficiency study group. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939-945, 1996
100. Torres VE, Mujwid DK, Wilson DM, Holley KH: Renal cystic disease and ammoniagenesis in HamSPRD rats. J Am Soc Nephrol 5:1193-1200, 1994
101. Torres VE, Bengal RJ, Chini C, Dousa TP: Effect of extracellular acidification on generation of oxygen free radicals by LLC-PK1 cells. J Am Soc Nephrol 6:711, 1995 (abstr)
102. Gile RD, Cowley BD, Jr, Gattone VH II, O'Donnell MP, Swan SK, Grantham JJ: Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat. Am J Kidney Dis 26:501-507, 1995
103. Gattone VH II, Cowley BD, Jr, Barash BD, Nagao S, Takahashi H, Yamaguchi T, Grantham JJ: Methylprednisolone retards the progression of inherited polycystic kidney disease in rodents. Am J Kidney Dis 25:302-313, 1995
104. Woo DD, Miao SYP, Pelayo JC, Woolf AS: Taxol inhibits progression of congenital polycystic kidney disease. Nature 368:750-753, 1994
105. Martinez JR, Grantham JJ, Cowley BD, Jr: Effect of paclitaxel (Taxol) on the progression of polycystic kidney disease in rodents. J Am Soc Nephrol 6:702, 1995 (abstr)